Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study).
Alfonso F, Cuesta J, Ojeda S, Camacho-Freire S, García Del Blanco B, Vaquerizo B, Zueco J, Trillo R, Mauri J, Velázquez M, Córdoba-Soriano JG, Serra A, Navarro F, Pan M, Díaz J, Otaegui I, Salvatella N, De la TorreHernandez JM, Val DD, Bastante T, Rivero F; Under the auspices of the Association of Interventional Cardiology of the Spanish Society of Cardiology. Alfonso F, et al. Among authors: salvatella n. Am J Cardiol. 2022 Jan 1;162:31-40. doi: 10.1016/j.amjcard.2021.09.027. Am J Cardiol. 2022. PMID: 34903344 Clinical Trial.
Coronary Endothelium-Dependent Vasomotor Function After Drug-Eluting Stent and Bioresorbable Scaffold Implantation.
Gomez-Lara J, Oyarzabal L, Ortega-Paz L, Brugaletta S, Romaguera R, Salvatella N, Roura G, Rivero F, Fuentes L, Alfonso F, Otaegui I, Vandeloo B, Vaquerizo B, Sabate M, Comin-Colet J, Gomez-Hospital JA. Gomez-Lara J, et al. Among authors: salvatella n. J Am Heart Assoc. 2021 Nov 16;10(22):e022123. doi: 10.1161/JAHA.121.022123. Epub 2021 Nov 3. J Am Heart Assoc. 2021. PMID: 34729992 Free PMC article.
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.
Romaguera R, Salinas P, Gomez-Lara J, Brugaletta S, Gómez-Menchero A, Romero MA, García-Blas S, Ocaranza R, Bordes P, Kockar MJ, Salvatella N, Jiménez-Díaz VA, Alameda M, Trillo R, Lee DH, Martín P, López-Benito M, Freites A, Pascual-Tejerina V, Hernández-Hernández F, Blanco BGD, Mohandes M, Bosa F, Pinar E, Roura G, Comin-Colet J, Fernández-Ortiz A, Macaya C, Rossello X, Sabate M, Pocock SJ, Gómez-Hospital JA; SUGAR trial investigators. Romaguera R, et al. Among authors: salvatella n. Eur Heart J. 2022 Mar 31;43(13):1320-1330. doi: 10.1093/eurheartj/ehab790. Eur Heart J. 2022. PMID: 34735004 Free PMC article. Clinical Trial.
Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial.
Colombo A, Chieffo A, Frasheri A, Garbo R, Masotti-Centol M, Salvatella N, Oteo Dominguez JF, Steffanon L, Tarantini G, Presbitero P, Menozzi A, Pucci E, Mauri J, Cesana BM, Giustino G, Sardella G. Colombo A, et al. Among authors: salvatella n. J Am Coll Cardiol. 2014 Nov 18-25;64(20):2086-97. doi: 10.1016/j.jacc.2014.09.008. Epub 2014 Sep 15. J Am Coll Cardiol. 2014. PMID: 25236346 Free article. Clinical Trial.
Multivessel disease in patients over 75years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI+75 nation-wide registry.
de La Torre Hernandez JM, Gomez Hospital JA, Baz JA, Brugaletta S, Perez de Prado A, Linares JA, Lopez Palop R, Cid B, Garcia Camarero T, Diego A, Gutierrez H, Fernandez Diaz JA, Sanchis J, Alfonso F, Blanco R, Botas J, Navarro Cuartero J, Moreu J, Bosa F, Vegas JM, Elizaga J, Arrebola AL, Hernandez F, Salvatella N, Monteagudo M, Gomez Jaume A, Carrillo X, Martin Reyes R, Lozano F, Rumoroso JR, Andraka L, Dominguez AJ. de La Torre Hernandez JM, et al. Among authors: salvatella n. Cardiovasc Revasc Med. 2018 Jul-Aug;19(5 Pt B):580-588. doi: 10.1016/j.carrev.2017.12.004. Epub 2017 Dec 6. Cardiovasc Revasc Med. 2018. PMID: 29306670
Coronary vasomotor function and myocardial flow with bioresorbable vascular scaffolds or everolimus-eluting metallic stents: a randomised trial.
Gomez-Lara J, Salvatella N, Romaguera R, Brugaletta S, Ñato M, Roura G, Ferreiro JL, Teruel L, Gracida M, Sabate M, Vaquerizo B, Cequier À, Gomez-Hospital JA; Collaborators. Gomez-Lara J, et al. Among authors: salvatella n. EuroIntervention. 2020 Jun 12;16(2):e155-e163. doi: 10.4244/EIJ-D-18-01203. EuroIntervention. 2020. PMID: 31217148 Free article. Clinical Trial.
Real-World Multicenter Coronary Lithotripsy Registry: Long-Term Clinical Follow-Up.
Cubero-Gallego H, Calvo-Fernandez A, Tizon-Marcos H, Aparisi A, Gomez-Lara J, Amat-Santos I, Fuertes M, Santos-Martinez S, Salvatella N, Garcia-Guimaraes M, Negrete A, Mohandes M, Gomez-Hospital JA, Moris C, Vaquerizo B. Cubero-Gallego H, et al. Among authors: salvatella n. J Invasive Cardiol. 2022 Oct;34(10):E701-E708. doi: 10.25270/jic/22.00058. Epub 2022 Aug 30. J Invasive Cardiol. 2022. PMID: 36075883 Free article.
Microvascular dysfunction and invasive absolute coronary flow after percutaneous coronary intervention for a chronic total occlusion. The FLOW-CTO study.
García-Guimarães M, Gutiérrez-Barrios A, Gómez-Lara J, Aparisi Á, Salvatella N, Rivero F. García-Guimarães M, et al. Among authors: salvatella n. Rev Esp Cardiol (Engl Ed). 2022 Sep;75(9):769-771. doi: 10.1016/j.rec.2022.03.008. Epub 2022 Jun 2. Rev Esp Cardiol (Engl Ed). 2022. PMID: 35662521 English, Spanish. No abstract available.
51 results